These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia. Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154 [TBL] [Abstract][Full Text] [Related]
3. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients. Elalamy I; Chakroun T; Gerotziafas GT; Petropoulou A; Robert F; Karroum A; Elgrably F; Samama MM; Hatmi M Thromb Res; 2008; 121(6):843-8. PubMed ID: 17825880 [TBL] [Abstract][Full Text] [Related]
4. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease]. Grifò G; Lo Presti R; Montana M; Canino B; Caimi G Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474 [TBL] [Abstract][Full Text] [Related]
5. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Tan KT; Tayebjee MH; Lim HS; Lip GY Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308 [TBL] [Abstract][Full Text] [Related]
6. [Circulating blood platelet aggregates in various diseases]. Donner L; Setková O; Tomásková K Vnitr Lek; 1983 Apr; 29(4):313-9. PubMed ID: 6868406 [No Abstract] [Full Text] [Related]
7. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events. Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349 [TBL] [Abstract][Full Text] [Related]
8. Platelet abnormalities in diabetes mellitus. Glassman AB Ann Clin Lab Sci; 1993; 23(1):47-50. PubMed ID: 8431000 [TBL] [Abstract][Full Text] [Related]
9. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Ravindran R; Krishnan LK Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614 [TBL] [Abstract][Full Text] [Related]
10. Detection of prethrombotic states in patients with atherosclerotic lesions. Breddin K Semin Thromb Hemost; 1986 Apr; 12(2):110-23. PubMed ID: 3526555 [No Abstract] [Full Text] [Related]
11. [Demonstration of spontaneous platelet aggregation and research on circulating platelet aggregates: methodology, results and significance]. Lecrubier C; Conard J; Horellou MH; Samama M Ann Biol Clin (Paris); 1983; 41(1):17-21. PubMed ID: 6869939 [TBL] [Abstract][Full Text] [Related]
12. Blood viscosity and thrombosis: clinical considerations. Smith BD; La Celle PL Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612 [TBL] [Abstract][Full Text] [Related]
13. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation]. Kostić N; Secen S Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685 [TBL] [Abstract][Full Text] [Related]